Here's What's Happenning

Consider seeking reimbursement for your medical technology’s clinical trial to help long-term commercialization efforts.

A short experiment by medical device reimbursement consultants with Chat GPT to see how useful it is for learning about medical device reimbursement strategy.

Argenta relays how marketing messages to physicians and patients may prompt payers to prioritize medical technology to an evidence-based coverage policy.

Argenta Advisors explains how preparing foundational information ahead of meeting w/ a reimbursement consultant can help your strategy or market access plan.

Argenta Advisors explores how to be successful in launching a digital health therapeutic, innovators will need to be aware of the following six critical reimbursement mistakes they are making. Learn more.

Argenta Advisors understands reimbursement strategy means understanding the need to demonstrate demand for a new technology to health insurance payers.

Prior “aggressive” tactics of manufacturers launching new technology can poison the reimbursement environment for a related, but distinct technology occupying the same space. This discussion traces the history of two of the most challenging reimbursement environments: wound healing and spine technologies.

Argenta Advisors relays how to void the common mistakes that can permanently haunt the reimbursement and market access efforts for new medical devices.

Argenta Advisors can you refine your medical technology’s reimbursement strategy and message to impress medical director focus groups. Learn More.